OrthoSpace is a privately held medical device company located in Caesarea, Israel. The company’s product, InSpace, is an orthopedic biodegradable balloon system that is a simple, safe and minimally invasive method that addresses unmet clinical needs in rotator cuff repair. InSpace is CE Marked and commercialized in Europe, Israel and Russia, as well as in several countries in Asia and Latin America. In the United States, the company has been granted an Investigational Device Exemption (IDE) to conduct a pivotal human clinical study of the system.

OrthoSpace’s InSpace is an implantable biodegradable balloon system that is implanted in a minimally invasive procedure in an inpatient or outpatient setting. Once the spacer is implanted in the subacromial space of the shoulder, there is no friction between the bones, and pain is reduced. This reduction in pain enables the body to recuperate faster than when undergoing comparable surgical treatments.

InnovaHealth Partners’ predecessor firm, HealthpointCapital, invested in OrthoSpace in 2015. Mortimer Berkowitz III currently serves as Chairman and Ariella Golomb, M.D. is a Director of OrthoSpace.